| Miss Ellen Leigh Hearty, MD | |
|
119 Hendersonville Rd, Asheville, NC 28803-2868 | |
| (828) 771-5537 | |
| Not Available |
| Full Name | Miss Ellen Leigh Hearty |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 119 Hendersonville Rd, Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114365749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 2014-01758 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Mcdowell Hospital | Marion, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mh Blue Ridge Medical Center, Lllp | 2769715671 | 23 |
| Mh Mission Hospital Mcdowell, Lllp | 0345581856 | 44 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.
Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.
› Verified 9 days ago
| Entity Name | The Mcdowell Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699772657 PECOS PAC ID: 2264343979 Enrollment ID: O20031107000487 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.
Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.
› Verified 9 days ago
| Entity Name | Blue Ridge Regional Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447261698 PECOS PAC ID: 0648181966 Enrollment ID: O20040729001574 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.
Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.
› Verified 9 days ago
| Entity Name | Mission Health Community Multispecialty Providers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.
Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.
› Verified 9 days ago
| Entity Name | Mh Blue Ridge Medical Center, Lllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720556269 PECOS PAC ID: 2769715671 Enrollment ID: O20191115001609 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.
Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.
› Verified 9 days ago
| Entity Name | Mh Mission Hospital Mcdowell, Lllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225513948 PECOS PAC ID: 0345581856 Enrollment ID: O20191119001720 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.
Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Ellen Leigh Hearty, MD 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 771-5537 | Miss Ellen Leigh Hearty, MD 119 Hendersonville Rd, Asheville, NC 28803-2868 Ph: (828) 771-5537 |
News Archive
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Multivalent protein-based minibinders hold great promise as potential prophylactic and treatment agents, as they can retain their activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. This was revealed in a recent tour-de-force research study currently available on the bioRxiv* preprint server while the article undergoes the peer review process.
Avisio, Inc. (PINKSHEETS: AVIC), a publicly traded commercialization company providing access to best-of-breed processes and resources, today announced that it has signed a Letter of Intent to acquire a portable sensory technology asset that enables instant detection of infectious diseases, eliminating the need for processing samples in a lab.
The benefits of vitamin D in promoting bone health are already well known. A new study out of Brazil suggests that vitamin D also may promote greater insulin sensitivity, thus lowering glucose levels and the risk of developing type 2 diabetes.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., today announced that it has received clearance from the Therapeutic Goods Administration (TGA) for its illumigene Group B Streptococcus (GBS) test, the newest molecular product on the illumigene platform.
› Verified 9 days ago
Dr. Ruchi Patel Moore, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 Oakland Rd, Suite 200, Asheville, NC 28801 Phone: 828-253-5381 Fax: 828-253-9087 | |
Dr. Ursula Fritzi Harkness, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5504 Fax: 828-771-5479 | |
Dr. Summer Kimberly Gilmer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 41 Oakland Road, Suite 200, Asheville, NC 28801 Phone: 828-253-5381 Fax: 828-253-9087 | |
Elizabeth S. Garbarino, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 40 N Merrimon Ave, Asheville, NC 28804 Phone: 828-575-9562 Fax: 828-575-2884 | |
Sarah Jones, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 143 Asheland Ave, Asheville, NC 28801 Phone: 828-258-9191 | |
Patricia Mae Engel Overcarsh, M.D., M.P.H. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5500 Fax: 828-257-4750 | |
Bhaskari Burra, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 119 Hendersonville Rd, Asheville, NC 28803 Phone: 828-771-5500 Fax: 828-257-4750 |